Esco Aster Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Esco Aster's estimated annual revenue is currently $7.1M per year.(i)
  • Esco Aster's estimated revenue per employee is $155,000

Employee Data

  • Esco Aster has 46 Employees.(i)
  • Esco Aster grew their employee count by -26% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M63-24%$15MN/A
#2
$20M129-16%$150MN/A
#3
$3.7M48-6%$53MN/A
#4
$5.4M35-8%N/AN/A
#5
$3.6M23-18%N/AN/A
#6
$3.4M220%N/AN/A
#7
$5.4M356%N/AN/A
#8
$7.1M46-26%N/AN/A
#9
$36.1M2334%N/AN/A
#10
$3.1M20-61%N/AN/A
Add Company

What Is Esco Aster?

At Esco Aster we are a contract development and manufacturing organization founded and deeply rooted by scientists enabling fellow scientists to translate their bench work into life-saving diagnostics, medicines, therapies, cosmeceuticals, cellular agriculture, at affordable prices for their country self sufficiency. We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome with track record of being used in 7 commercial human and animal health vaccines. We continuously invest in meeting unmet clinical needs by unblocking manufacturing bottlenecks for current and new platform modalities. Together, we are working on a interconnected one health approach to bring your next molecule into clinic and life. Join us for the world we are making redefining medicine for current and future generations to come. Esco Aster. One World. One Health.

keywords:N/A

N/A

Total Funding

46

Number of Employees

$7.1M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Esco Aster News

2022-04-19 - Étude du marché mondial des capteurs à usage unique 2022 ...

... mondial des capteurs à usage unique 2022-2029 et analyse de la croissance par les acteurs clés Equflow, PARKER, PendoTECH, Esco Aster.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M4610%N/A
#2
$5.2M4628%N/A
#3
$6.6M46-4%N/A
#4
$10.2M470%N/A
#5
$5.3M47N/AN/A